Learning

January 23, 2019

Ribonucleic acid-based therapy for enhancing memory and cognition: LncRNA DIGIT increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down-regulation of its target genes, 23/January/2019, 11.41 am

Ribonucleic acid-based therapy for enhancing memory and cognition: LncRNA DIGIT increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down-regulation of its target genes, 23/January/2019, 11.41 am https://genomediscovery.org/wp-content/uploads/2019/01/LncRNA-DIGIT-inhibits-age-associated-decline-of-hippocambal-function-and-enhances-learning-cognition-and-memory.jpg2_.jpg2_.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2019/01/LncRNA-DIGIT-inhibits-age-associated-decline-of-hippocambal-function-and-enhances-learning-cognition-and-memory.jpg2_.jpg2_.jpg January 23, 2019 January 23, 2019

Introduction: What they say: A study from Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California 94305, USA; Paul F. Glenn Center for the Biology of…

January 22, 2019

Ribonucleic acid-based therapy for enhancing memory and cognition: LncRNA CYTOR increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down-regulation of its target genes, 22/January/2019, 11.23 pm

Ribonucleic acid-based therapy for enhancing memory and cognition: LncRNA CYTOR increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down-regulation of its target genes, 22/January/2019, 11.23 pm https://genomediscovery.org/wp-content/uploads/2019/01/LncRNA-CYTOR-inhibits-age-associated-decline-of-hippocambal-function-and-enhances-learning-cognition-and-memory.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2019/01/LncRNA-CYTOR-inhibits-age-associated-decline-of-hippocambal-function-and-enhances-learning-cognition-and-memory.jpg January 22, 2019 January 22, 2019

November 25, 2018

Mechanistic insights into how XBP-1 enhances learning, memory and cognition: XBP-1 increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down-regulation of its target genes, 25/November/2018, 8.01 am

Mechanistic insights into how XBP-1 enhances learning, memory and cognition: XBP-1 increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down-regulation of its target genes, 25/November/2018, 8.01 am https://genomediscovery.org/wp-content/uploads/2018/11/XBP1-inhibits-age-associated-decline-of-hippocambal-function-and-enhances-learning-cognition-and-memory.jpg2_.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/11/XBP1-inhibits-age-associated-decline-of-hippocambal-function-and-enhances-learning-cognition-and-memory.jpg2_.jpg November 25, 2018 November 25, 2018

November 24, 2018

Mechanistic insights into how MANF enhances learning, memory and cognition: Mesencephalic astrocyte-derived neurotrophic factor (MANF) increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down-regulation of its target genes, 24/November/2018, 10.42 pm

Mechanistic insights into how MANF enhances learning, memory and cognition: Mesencephalic astrocyte-derived neurotrophic factor (MANF) increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down-regulation of its target genes, 24/November/2018, 10.42 pm https://genomediscovery.org/wp-content/uploads/2018/11/MANF-functions-as-an-antistroke-agent-by-increasing-the-expression-of-BDNF-NAMPT1.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/11/MANF-functions-as-an-antistroke-agent-by-increasing-the-expression-of-BDNF-NAMPT1.jpg November 24, 2018 November 24, 2018

November 23, 2018

Valproic acid-based learning/memory/cognitive-enhancement therapy: Valproic acid (brand name: Convulex, Stavzor, and others), used in the treatment of epilepsy, bipolar disorder and migraine, increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down-regulation of its target genes, 23/November/2018, 7.07 am

Valproic acid-based learning/memory/cognitive-enhancement therapy: Valproic acid (brand name: Convulex, Stavzor, and others), used in the treatment of epilepsy, bipolar disorder and migraine, increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down-regulation of its target genes, 23/November/2018, 7.07 am https://genomediscovery.org/wp-content/uploads/2018/11/Valproic-acid-inhibits-age-associated-decline-of-hippocambal-function-and-enhances-learning-cognition-and-memory.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/11/Valproic-acid-inhibits-age-associated-decline-of-hippocambal-function-and-enhances-learning-cognition-and-memory.jpg November 23, 2018 November 23, 2018

November 22, 2018

Mechanistic insights into how anesthetic agent Hyoscine may deteriorate memory, learning, and cognition: Hyoscine (trade name: Transdermscop and others), a local anesthetic agent, decreases Tissue inhibitor of metalloproteinases 2 (TIMP2) and BDNF levels, attenuates cognition, and aggravates age-associated decline in memory and learning, via up-regulation of its target genes, 22/November/2018, 10.56 pm

Mechanistic insights into how anesthetic agent Hyoscine may deteriorate memory, learning, and cognition: Hyoscine (trade name: Transdermscop and others), a local anesthetic agent, decreases Tissue inhibitor of metalloproteinases 2 (TIMP2) and BDNF levels, attenuates cognition, and aggravates age-associated decline in memory and learning, via up-regulation of its target genes, 22/November/2018, 10.56 pm https://genomediscovery.org/wp-content/uploads/2018/11/Hyoscine-inhibits-age-associated-decline-of-hippocambal-function-and-enhances-learning-cognition-and-memory.jpg3_.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/11/Hyoscine-inhibits-age-associated-decline-of-hippocambal-function-and-enhances-learning-cognition-and-memory.jpg3_.jpg November 22, 2018 November 22, 2018

Introduction: What they say A study from Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California 94305, USA; Paul F. Glenn Center for the Biology of…

Ribonucleic acid-based therapy for enhancing memory and cognition: LncRNA DIGIT increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down-regulation of its target genes, 23/January/2019, 11.41 am

Ribonucleic acid-based therapy for enhancing memory and cognition: LncRNA CYTOR increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down-regulation of its target genes, 22/January/2019, 11.23 pm

Mechanistic insights into how XBP-1 enhances learning, memory and cognition: XBP-1 increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down-regulation of its target genes, 25/November/2018, 8.01 am

Popular Post